Preclinical publications

Papers and presentations from the Preclinical program.

14 items

All publications and presentations

October 2021
Presentation
Therapeutic benefits of MSC-NTF (NurOwn®) exosomes in acute lung injury models2021 NYSCF ConferenceView source
January 2021
Peer-reviewed
MSC-NTF (NurOwn) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS modelStem Cell Research & TherapyView source
November 2017
Peer-reviewed
miRNA profiling of NurOwn: mesenchymal stem cells secreting neurotrophic factorsStem Cell Research & TherapyView source
2017
Peer-reviewed
Long term beneficial effect of neurotrophic factors-secreting mesenchymal stem cells transplantation in the BTBR mouse model of autismBehavioural Brain ResearchView source
2017
Peer-reviewed
Concise review: mesenchymal stem cells in neurodegenerative diseasesStem CellsView source
2012
Peer-reviewed
Intrastriatal transplantation of neurotrophic factor-secreting human mesenchymal stem cells improves motor function and extends survival in R6/2 transgenic mouse model for Huntington’s diseasePLoS CurrView source
2012
Peer-reviewed
Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington’s diseaseExp NeurolView source
2012
Peer-reviewed
Differentiated mesenchymal stem cells for sciatic nerve injuryExp NeurolView source
2010
Peer-reviewed
Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transectionInvest Ophthalmol Vis SciView source
2009
Peer-reviewed
Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosisJ Mol NeurosciView source
2009
Peer-reviewed
Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson diseaseStem Cells and DevelopmentView source
2009
Peer-reviewed
Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseasesIsr Med Assoc JView source
2009
Peer-reviewed
Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson’s diseaseJ Mol NeurosciView source
2008
Peer-reviewed
Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imagingStem CellsView source

BrainStorm's autologous MSC-NTF cell therapy (NurOwn^®, debamestrocel) is investigational and has not been approved by the FDA or any other regulatory authority.